Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
9,795 total articles
David E. Cohen, a director at Evommune, Inc., recently sold a total of $123,093 worth of common stock through a pre-arranged trading plan. Concurrently, the filings detail his acquisition of 15,673 stock options. This activity is reported against a backdrop of recent company news, including the Q1 loss surpassing expectations and an analyst reitera…
The recent sale of common stock by Evommune's President & CEO, Luis C. Pena, signals specific insider activity while the company navigates mixed financial results and positive developments in its drug development pipeline. The transaction details are provided alongside current market data, analyst ratings, and updates regarding a Phase 2b trial.
Halozyme Therapeutics CEO, Helen Torley, recently executed a sale of company stock totaling approximately $3.37 million after exercising vested options. This executive activity occurred while the company reported strong financial performance for Q1 2026, surpassing analyst expectations. Despite recent selling by top management and noted industry he…
The filing details show that Jeegar Pravinkumar Patel, Chief Scientific Officer of Evommune, Inc. (NASDAQ:EVMN), executed a series of transactions involving the company's common stock on June 1, 2026. These filings reveal both the sale of shares and the acquisition of additional equity through option exercises. These insider movements are analyzed …
The Chief Operating Officer of CoreWeave, Inc. executed a sale of company stock totaling $455,760. This transaction occurred against the backdrop of significant corporate developments for CoreWeave, including raising $900 million through a high-yield bond and advancing its AI cloud platform capabilities.
Chief Operating Officer Michael Wittmann of indie Semiconductor, Inc. (NASDAQ:INDI) recently sold 37,500 shares of Class A Common Stock through a pre-arranged trading plan. This transaction occurred on June 2, 2026, at prices ranging from $4.94 to $5.29. These sales follow the vesting of Restricted Stock Units (RSUs) for Wittmann, which also includ…
Javier Olivan, Chief Operating Officer at Meta Platforms, Inc., executed a sale totaling $922,539 worth of company stock. These sales were conducted through pre-established Rule 10b5-1 trading plans. The transaction details are set against the backdrop of Meta's recent advancements in AI tools and ongoing regulatory shifts concerning its platforms.
CECO Environmental Corp. director Richard F. Wallman recently acquired a significant block of common stock through an indirect purchase, signaling internal interest. This activity occurs against a backdrop of robust company performance, including first-quarter earnings that surpassed expectations and a strategic merger with Thermon Group Holdings. …
Anirudh Devgan, President and CEO of Cadence Design Systems Inc., recently executed sales of company stock totaling approximately $30.8 million. These transactions occurred while the stock was trading near its 52-week high. Separately, the company has been highlighted by major financial institutions for strong earnings results and strategic collabo…
Chief Operating Officer Benjamin E. Huston recently executed a series of transactions involving Carvana Co.'s Class A Common Stock, including the sale of 50,000 shares valued at $3,519,605 and the acquisition of an equal number of shares through option exercise. These filings occurred alongside other stock disposals related to restricted stock unit…
Paul Scannell, Senior Vice President at Cadence Design Systems Inc., executed a series of common stock transactions on June 1, 2026. These actions included selling shares while simultaneously acquiring others through the exercise of non-qualified stock options. This activity occurred as CDNS stock trades near its 52-week high and amid positive anal…
Ten percent owning entities, Eagle Point Credit Management LLC and Eagle Point DIF GP I LLC, executed sales of ACRES Commercial Realty Corp. (ACR) preferred stock totaling $157,032 on June 1 and June 3, 2026. These transactions occurred as ACR's common stock declined nearly 4% in the past week to reach $19.09, marking a substantial decline of 15% o…
Snowflake director Frank Slootman executed a sizable sale of common stock totaling approximately $43 million. This transaction occurred after he exercised vested options to acquire 162,924 shares. Separately, the company has received positive analyst attention following its recent annual user conference and investor day, with firms raising price ta…
Carvana's CFO, Mark W. Jenkins, executed transactions involving the sale of Class A common stock and the exercise of options on June 1, 2026, utilizing a Rule 10b5-1 trading plan. These sales occurred alongside the company's recent announcement of a five-for-one stock split. Furthermore, the firm has seen multiple analyst upgrades from major financ…
Christian Kleinerman, Executive Vice President of Product Management at Snowflake Inc., recently sold a total value of $2.72 million in the company's common stock. These transactions were completed on June 1, 2026, and involved 10,000 shares. The sales occurred under a pre-arranged 10b5-1 trading plan that Mr. Kleinerman had initiated on December 2…
Corcept Therapeutics' President, Sean Maduck, executed multiple transactions involving the company's common stock in early June 2026. These sales and acquisitions occurred against a backdrop of strong market performance for CORT. Furthermore, the company recently reported its Q1 2026 earnings and presented positive Phase 3 trial data for Lifyorli, …
Recent insider trading activity at Corcept Therapeutics Inc. (NASDAQ:CORT) included the sale of shares by CFO Mokari Atabak, which occurred under a pre-arranged 10b5-1 plan. The report details multiple transactions involving Mr. Atabak on June 1 and 2, 2026. Beyond these corporate actions, the article provides significant clinical and financial upd…
Director Steven Pei made multiple purchases of Comstock Inc.'s common stock totaling approximately $1.45 million in early June, according to SEC filings. This activity occurred alongside the release of Q1 2026 financial results for Comstock Mining, which reported a net loss but also raised significant capital through equity financing.
Director Luke Evnin of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) executed multiple sales of the company's common stock between June 1 and June 3, 2026, divesting a total of 139,803 shares valued at approximately $63,628.These transactions were conducted under a Rule 10b5-1 trading plan established previously. The timing of the sales occurred while …
The recent transaction by AdaptHealth Corp.'s Chief Commercial Officer, Russell E. Schuster III, coupled with the company's first quarter 2026 financial results, presents a complex picture for investors. While Q1 2026 revenue exceeded expectations, the earnings per share figure fell short, leading to market apprehension and drawing close scrutiny o…
Stephen R. Palmer, VP of Accounting at Carvana Co., executed pre-planned sales of company stock totaling $352,100 in June 2026. This insider activity occurred against a backdrop of strong corporate financial performance, including reported EBITDA surpassing expectations, which has prompted multiple major investment banks to raise their price target…
Charles H. Giancarlo, a director at Arista Networks, Inc., recently sold company stock totaling over $1.35 million. This sale was executed through a pre-arranged Rule 10b5-1 trading plan. The transaction occurred as the stock approaches its 52-week high following strong Q1 earnings results and subsequent positive adjustments from major investment b…
Jose A. Fernandez, Co-Chief Operating Officer of StepStone Group Inc., sold approximately $9.61 million worth of company shares between June 1 and June 3, 2026, utilizing a Rule 10b5-1 trading plan. This activity occurs as the stock has declined significantly over the past week. Separately, the company recently reported strong financial performance…
Symbotic director Charles Kane executed a sale of 2,000 shares of Class A Common Stock on June 1, 2026. This transaction was conducted through a pre-arranged 10b5-1 plan and followed the redemption of 2,000 Symbotic Holdings Units. The activity occurred as the company's stock has declined recently, contrasting with its strong performance over the p…
Director Todd Krasnow executed a planned sale of Symbotic Inc. Class A Common Stock shares valued at $94,603. This transaction occurred as the stock faced significant downward volatility despite maintaining gains over the past year. The report also details Symbotic's mixed second-quarter fiscal year 2026 financial results, noting that while revenue…
